Identifying tests related to breast cancer care in claims data

Benjamin L. Franc, Robert Thombley, Yanting Luo, W. John Boscardin, Hope S. Rugo, David Seidenwurm, R. Adams Dudley

Research output: Contribution to journalArticlepeer-review

Abstract

To develop a method for calculating rates of testing for breast cancer recurrence in patients who have already undergone initial treatment for breast cancer, we calculated rates in a cohort of Medicare breast cancer patients and an age-matched noncancer cohort. We first used only tests with claims including diagnosis codes indicating invasive breast cancer and then used all tests regardless of diagnosis code. For each method, we calculated testing rates in the breast cancer cohort above the background rate in the noncancer population. The two methods provided similar estimates of testing prevalence and frequency, with exception of prevalence of CT.

Original languageEnglish (US)
Pages (from-to)1227-1230
Number of pages4
JournalBreast Journal
Volume26
Issue number6
DOIs
StatePublished - Jun 1 2020
Externally publishedYes

Bibliographical note

Funding Information:
This study used the linked SEER‐Medicare data base. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the National Cancer Institute; the Office of Research, Development and Information, CMS; Information Management Services (IMS), Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER‐Medicare data base.

Funding Information:
This work was funded by grant 1R01HS024936-01 from the Agency for Health care Research and Quality This study used the linked SEER-Medicare data base. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the National Cancer Institute; the Office of Research, Development and Information, CMS; Information Management Services (IMS), Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER-Medicare data base.

Publisher Copyright:
© 2019 Wiley Periodicals, Inc.

Keywords

  • breast cancer
  • imaging utilization
  • surveillance epidemiology and end results
  • test utilization

PubMed: MeSH publication types

  • Journal Article
  • Research Support, U.S. Gov't, P.H.S.

Fingerprint

Dive into the research topics of 'Identifying tests related to breast cancer care in claims data'. Together they form a unique fingerprint.

Cite this